B-lymphocyte subpopulations in patients with selective IgA deficiency. 2012

Jana Nechvatalova, and Zdenka Pikulova, and Dagmar Stikarovska, and Sava Pesak, and Marcela Vlkova, and Jiri Litzman
Department of Clinical Immunology and Allergology, St. Anne's University Hospital, Faculty of Medicine, Masaryk University, Pekarska 53, 656 91, Brno, Czech Republic.

BACKGROUND Selective deficiency IgA (IgAD) is the most common primary abnormality of immunoglobulin production with unknown pathophysiology. It is genetically related to common variable immunodeficiency (CVID), where besides IgA also IgG and frequently IgM serum levels are decreased. In this study we focused on determination of B-lymphocyte developmental stages and searching for similarities between CVID and IgAD. METHODS Using flow cytometry we determined major lymphocyte subpopulations and B-lymphocyte subsets: naïve (CD27(-)IgD(+)), marginal zone cells (CD27(+)IgD(+)), class-switched memory cells (CD27(+)IgD(-)), "double-negative" B cells (CD27(-)IgD(-)), transitional cells (IgM(++)CD38(++)), plasmablasts (CD38(+++)IgM(+) or IgM(-)), and CD21(low)CD38(low) cells in 80 patients with IgAD, 48 patients with CVID, and 80 control persons. RESULTS Compared to healthy controls, a decrease in the absolute number and frequency of CD4+ cells (both < 0.001) was observed in IgAD patients. A decrease in the frequency of switched memory cells (P < 0.001), transitional cells (P = 0.035) as well as plasmablasts (P < 0.001) and an increase in the CD21(low)CD38(low) subset (P = 0.007) was observed in IgAD patients compared to control persons. No significant differences were observed in the remaining B-cell developmental subsets. A decrease in CD27(+)IgD(-) (<0.4% of peripheral blood lymphocytes), frequently observed in CVID patients and also previously reported in IgAD, was found in only five patients (6%) with IgAD, two of them being first-degree relatives of CVID patients. CONCLUSIONS Our results show a decrease of terminally differentiated B-lymphocyte subsets in patients with IgAD, similar as previously found in patients with CVID, but these results are less expressed than in CVID patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D016175 B-Lymphocyte Subsets A classification of B-lymphocytes based on structurally or functionally different populations of cells. B-Cell Subsets,Tumor-Infiltrating B Cells,Tumor-Infiltrating B Lymphocytes,B Effector 1 Cells,B Effector 2 Cells,B-1 Cells,B-1 Lymphocytes,B-2 Lymphocytes,B-Lymphocytes, Effector,B1 Lymphocytes,B2 Lymphocytes,Be1 Cells,Be2 Cells,Effector B Cells,B 1 Cells,B 1 Lymphocytes,B 2 Lymphocytes,B Cell Subsets,B Cell, Tumor-Infiltrating,B Lymphocyte Subsets,B Lymphocyte, Tumor-Infiltrating,B-1 Cell,B-1 Lymphocyte,B-2 Lymphocyte,B-Cell Subset,B-Lymphocyte Subset,B-Lymphocyte, Effector,B1 Lymphocyte,B2 Lymphocyte,Be1 Cell,Be2 Cell,Cell, B-1,Cell, Be1,Cell, Be2,Effector B Cell,Effector B-Lymphocyte,Effector B-Lymphocytes,Lymphocyte, B-1,Lymphocyte, B-2,Lymphocyte, B1,Lymphocyte, B2,Tumor Infiltrating B Cells,Tumor Infiltrating B Lymphocytes,Tumor-Infiltrating B Cell,Tumor-Infiltrating B Lymphocyte

Related Publications

Jana Nechvatalova, and Zdenka Pikulova, and Dagmar Stikarovska, and Sava Pesak, and Marcela Vlkova, and Jiri Litzman
January 1988, Revista do Hospital das Clinicas,
Jana Nechvatalova, and Zdenka Pikulova, and Dagmar Stikarovska, and Sava Pesak, and Marcela Vlkova, and Jiri Litzman
February 2007, Clinical and experimental immunology,
Jana Nechvatalova, and Zdenka Pikulova, and Dagmar Stikarovska, and Sava Pesak, and Marcela Vlkova, and Jiri Litzman
January 1990, The Turkish journal of pediatrics,
Jana Nechvatalova, and Zdenka Pikulova, and Dagmar Stikarovska, and Sava Pesak, and Marcela Vlkova, and Jiri Litzman
August 1982, Immunology letters,
Jana Nechvatalova, and Zdenka Pikulova, and Dagmar Stikarovska, and Sava Pesak, and Marcela Vlkova, and Jiri Litzman
January 2015, Journal of investigational allergology & clinical immunology,
Jana Nechvatalova, and Zdenka Pikulova, and Dagmar Stikarovska, and Sava Pesak, and Marcela Vlkova, and Jiri Litzman
March 2023, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology,
Jana Nechvatalova, and Zdenka Pikulova, and Dagmar Stikarovska, and Sava Pesak, and Marcela Vlkova, and Jiri Litzman
January 1988, International urology and nephrology,
Jana Nechvatalova, and Zdenka Pikulova, and Dagmar Stikarovska, and Sava Pesak, and Marcela Vlkova, and Jiri Litzman
December 1985, Orvosi hetilap,
Jana Nechvatalova, and Zdenka Pikulova, and Dagmar Stikarovska, and Sava Pesak, and Marcela Vlkova, and Jiri Litzman
February 1979, Clinical and experimental immunology,
Jana Nechvatalova, and Zdenka Pikulova, and Dagmar Stikarovska, and Sava Pesak, and Marcela Vlkova, and Jiri Litzman
February 1983, Immunology today,
Copied contents to your clipboard!